Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GLIPIZIDE
- A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
- Open-Label, Randomized, Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers
- Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
- Ertugliflozin: Cardioprotective Effects on Epicardial Fat
- Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Incretin-based Drugs and the Risk of Heart Failure
- Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
- Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
- A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
- Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus
- Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
- Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
- Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients
- To Demonstrate the Effect of Food on the Bioavailability of Glipizide
- To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
- Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
- 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting
- 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting
- Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA
- Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
- Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg
- Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg
- Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
- Dyslipidemia in Type 2 Diabetes (0767-034)
- MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)
- Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
- Insulin Glargine in Type 2 Diabetic Patients
- Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
- An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
- An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)
Clinical trials list
click for details